Global Cancer Crisis: Danger and Opportunities | Duke Kunshan University
Global Cancer Crisis: Danger and Opportunities
Prof. Nelson J. Chao

Chief of the Division of Hematological Malignancies and the Division of Cellular Therapy/BMT, Duke University

Sep 17th 2015 12:15 to 13:15
Room 1079, Academic Building
Wednesday, January 17, 2018 - 17:30

Summary of Talk:

Worldwide, non-communicable diseases have surpassed communicable diseases in incidence, morbidity and mortality. One of the major non communicable diseases is cancer. The burden of cancer in low to middle income countries (LMIC) is a silent slow moving crisis. The health care inequities between first world countries and LMIC is a major area of concern and these disparities have been gaining more awareness around the world especially in the area of health care funding and care delivery. The causes, and opportunities and potential solutions will require a broad societal and international collaborative approach.


Brief Biography:

Nelson J. Chao, MD, MBA, is the Donald D. and Elizabeth G. Cooke Professor in Cancer Research and Professor of Medicine and Immunology and the Chief of the Division of Hematological Malignancies and the Division of Cellular Therapy/BMT at Duke University. He received his undergraduate degree from Harvard University, MD from Yale University and his post-graduate training at Stanford University. He was the Associate Director of Stem Cell Transplantation at Stanford University prior to moving to Duke University in 1996 as the Director of the Bone Marrow Transplantation Program. The program was renamed as the Division of Cellular Therapy/BMT. He is also the Co-Director of the Clinical Stem Cell Transplantation Laboratory and continues to direct his own research laboratory focused on understanding and preventing graft-versus-host disease and improving immune reconstitution. He is also the Director of Global Cancer for the Duke Cancer Institute and the Duke Global Health Institute. In 2012, he has also become the Chief of the Division of Hematological Malignancies. He obtained his MBA from the Fuqua School of Business at Duke University in 2000. He is the author of approximately 250 peer-reviewed papers, 25 book chapters and one book. He is also a co-founder of two start up biotechnology companies in Research Triangle Park, Aldagen and C2 Regenerate. Nationally, he is the co-chair of the Radiation Injury Treatment Network (RITN) and the Principal Investigator for a Program Project Grant in stem cell transplantation and the Center for Medical Countermeasures against Radiation.